Biotech

All Articles

AstraZeneca pays CSPC $100M for preclinical heart problem medicine

.AstraZeneca has actually paid off CSPC Drug Team $one hundred thousand for a preclinical cardiovasc...

Zephyrm looks for Hong Kong IPO to fund stage 3 tissue therapy tests

.Zephyrm Bioscience is gusting toward the Hong Kong stock market, submission (PDF) for an IPO to sta...

Frazier Life Sciences gathers $630M for small, mid-cap biotechs

.Frazier Everyday life Sciences has actually sourced an additionally $630 million for its own fund c...

GigaGen garners as much as $135M BARDA money to beat botulism

.Antitoxin fan GigaGen, a subsidiary of Spanish biopharma Grifols, is ramping up its technician to t...

GPCR organization Septerna apply for IPO on stamina of preclinical data

.Septerna will figure out how a biotech without "any type of relevant scientific information" fares ...

Kurma closes to begin with $154M payload for biggest biotech fund yet

.European VC company Kurma Partners has revealed its most current biotech fund, with 140 million eur...

Prothena ensures one exec while another keeps-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of considerable leadership hirings, shootin...

Editas exploit Tip Cas9 licensing legal rights for $57M

.Versus the scenery of a Cas9 license war that refuses to die, Editas Medication is actually moneyin...

Ultragenyx changes genetics therapy application to dial up efficiency

.A minority of clients taking Ultragenyx Drug's Wilson health condition genetics treatment UX701 hav...

Biopharma layoff cost stabilizes in Q3: Brutal Biotech analysis

.As summer months warmth looks to cool down winds, wishes that this year will deliver prevalent mark...